Tiouririne headshot
NT

Nassima Ait-Daoud Tiouririne

Professor
Unit: School of Medicine
Department: Department of Psychiatry and NB Sciences
Office location and address
580 McCormick Rd
Charlottesville, Virginia 22903
Education
M.D., University of Medicine of Algiers, Algeria, 1992
Resident, University of Virginia
Biography

Dr. Tiouririne graduated from Algiers University in 1992 and trained in psychiatry both at Algiers and the Univeristy of Virginia. After joining professor Johnson's research team in 1997, first as a fellow and later as a faculty, Dr. Tiouririne developed special expertise in pharmacological treatment of alcoholism and other drugs of abuse. She is well experienced with clinical trials in addiction and is very familiar with FDA regulations and good clinical practice. She is a principal investigator on multiple NIH funded projects and a co-investigator on multiple other NIH funded grants.

Her special interests are medication development for the treatment of the addictions and understanding the underpinnings of drug craving associated with treatment response. She is an associate professor in the Department of Psychiatry and Neurobehavioral Science at UVA, as well as the director of the Center for Leading-Edge Addiction Research (UVA CLEAR). Dr. Tiouririne sees patients privately and with residents within the division of outpatient psychiatry. She teaches first year medical students, undergraduate students and residents and spends the rest of her time in her research clinic.

Developing Addiction services in the community through addiction medicine fellowship expansion
Source: U.S. Health Resources & Services Administration
July 01, 2020 – June 30, 2025
Preparing the new generation of providers to tackle the opioid epidemic through enhanced training and support
Source: U.S. Substance Abuse & Mental Health Ser. Admin.
September 30, 2019 – September 29, 2022
MD-PSYCH Clinical Research site for NIAAA
Source: U.S. NIH on Alcohol Abuse & Alcoholism
March 15, 2021 – March 14, 2022
Virginia Higher Education Opioid Consortium (VHEOC)
Source: Department of Behavioral Health and Developmental
May 13, 2019 – September 30, 2020
New Pharmacotherapy for Alcohol and Co-morbid Disorders
Source: U.S. NIH on Alcohol Abuse & Alcoholism
September 10, 2010 – August 31, 2016
MD-PSYCH VICTORY: Video Game Therapy for Substance Cessation and Recovery
Source: Barron Associates, Inc.
April 01, 2014 – August 31, 2015
MD-PSYC SPF SIG
Source: COUNTY OF ALBEMARLE
June 01, 2014 – May 31, 2015
New Medication Treatments for Stimulant Dependence
Source: U.S. NIH Institute on Drug Abuse
September 01, 2007 – December 31, 2013
  • 2010 - Editor in Chief of Frontiers in Addictive Behaviors
  • 2008 to Present - Active member of the NIAAA AA3 scientific review committee
  • July 2001 - Fellowship from the 7th World Congress of Biological Psychiatry 
  • June 2000 - MAAS Award
  • 1998-2000 - NIAAA Research Supplement Award for Minorities Recipient
  • 1999 - CPDD Registration Award
  • 1999 - ACNP Travel Award